CA
NZ
UK
AU
IND
US
Shares of Senseonics Holdings (NYSE American:SENS) surged about 8.2% as bulls returned to the diabetes-technology company behind the long-wear Eversense implantable continuous glucose monitor. The move extended the stock's reputation for sharp swings around its evolving growth story.
Tenon Medical (NASDAQ:TNON) rose sharply in mid-August trading, drawing attention to a micro-cap medical-device company that has strung together several notable developments over the summer. The move came on heavyVolumerelative to the company's small size, though a single, clearly disclosed catalyst for the surge …
Shares of Scribe Therapeutics (NASDAQ:SCTX) surged as traders returned to the recently public gene-editing company, one of the few CRISPR biotechs to complete an initial public offering in 2026. The move comes less than a month after Scribe debuted on theNasdaqGlobal Market, and it …
Shares of Tandem Diabetes Care (NASDAQ:TNDM) climbed about 6.6% in a session that put the diabetes-technology company back among the day's more active med-tech movers. The gain builds on an already strong August for the stock, which surged sharply after the company reported second-quarter …
Shares of YD Bio Limited (NASDAQ:YDES) rallied roughly 18% as traders piled into the small-cap biotechnology name. The Taipei-based company has laid out an unusually broad pipeline spanning cancer diagnostics, exosome therapies and stem cells, and its stock has become a vehicle for speculative …
Shares of NeOnc Technologies Holdings (NASDAQ:NTHI) jumped roughly 13% as investors reacted to freshly released clinical data for the company's lead brain-cancer candidate, NEO100. The move added the small-cap biotech to the growing list of speculative names catching momentum in mid-August 2026, and it …
Shares of Orchestra BioMed Holdings (NASDAQ:OBIO) jumped roughly 20% as the clinical-stage medical device company drew renewed attention from momentum traders. The move came days after the company delivered a detailed second-quarter update that reinforced its partnership-driven model and its progress toward late-stage cardiovascular …
Shares of ProQR Therapeutics (NASDAQ:PRQR) pushed sharply higher, gaining roughly 11% and returning the small-cap RNA-editing name to the watchlists of momentum traders. The move extends a recovery that has been building through the summer, though no single, freshly dated news release fully accounts …
Profusa (NASDAQ:PFSA) has turned into one of the most explosive and unpredictable micro-cap trades on Nasdaq, with the stock rocketing sharply higher after the company's latest reverse stock split took effect. The move fits a pattern that has defined PFSA all year: a tiny …
Xencor (NASDAQ:XNCR) surged nearly 10% in August 18, 2026 trading, closing around $25.41 and pushing the antibody-engineering company toward the top of its 52-week range of roughly $7.13 to $25.53. The move came on heavyVolumeof about 1.6 million shares and capped a strong run …
Please wait processing your request...